Supplier information: Covance Research Products
|
Covance Research Products are a leading provider of innovative antibody products and also offer a full range of immunology services. Covance's aquisition of the Signet product range has helped position Covance as a leading supplier of antibodies in the field of Alzhimer's, Parkinson's and other neurodegenerative diseases. The gold standard clones 6E10 and 4G8 for beta amyloid research heads over 600 antibodies for Alzheimer’s research. Covance is pleased to announce the availability of two new monoclonal antibodies specific to the E4 isoform of apolipoprotein E (Apo-E4). The addition of Apo-E4 clones 9D11 and 5G7 adds to Covance's growing portfolio of key products available for neurodegenerative disease research. APOD Matched Monoclonal Pairs Antibodies APOD Antibodies APOJ Antibodies APOE Antibodies Covance’s epitope tag antibodies are extremely specific, highly characterized and generate clear, quantitative results. Tagging reagents are available against most major epitope tags, including c-myc, HA.11, 6His and GFP. Epitope tag antibodies from Covance could be used for
Covance’s two new BetaMark ELISA kits for beta amyloid x-40 and x-42, offer researchers ultra sensitive tools for investigating the diagnostic and therapeutic value of these two beta amyloid peptides. Alzheimer’s is a disease that presently affects over five million people, a number that is expected to quadruple over the next fifteen years. There is no known cure and diagnosis can only be confirmed post mortem. Cerebrovascular deposition of beta amyloid protein is a common pathologic event in Alzheimer’s disease and certain related neurodegenerative disorders, and there is compelling evidence that the c-terminal cleavage point of beta amyloid determines the aggregation potential of the peptide.  Covance's neuroscience portfolio offers a wide range of high quality antibodies to key targets in neurodegenerative diseases including Alzheimer's, Parkinson's and prion disease. Their range of beta-Amyloid products, highlighted by the gold standards 6E10 and 4G8, includes the most comprehensive list of antibodies available for β-Amyloid and APP processing.
 |
|
| ||||
